News
The Pfizer Middle East, Russia and Africa (MERA) Maternal Immunization Summit: Born Ready brought together more than 80 ...
On 14 May 2025, the General Court of the EU ruled in favour of The New York Times in the much-awaited Pfizergate case, annulling the European Commission’s decision to withhold the SMS text messages ...
The Justice Department launched a probe into whether Chicago engaged in racially discriminatory hiring practices after Mayor ...
Immersive, the leader in people-centric cyber resilience, today announced the launch of its cutting-edge Operational Technology (OT) security solution to help organizations prove and improve their ...
The lyophilized injectable market is poised for growth due to increasing demand for biologics and specialty drugs, R&D activities, and global collabo ...
The Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...
The Coalition for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, ...
Juvenescence closes $76m first tranche of Series B-1 financing led by Abu Dhabi's M42 alongside strategic partnership <u ...
CALIFORNIA, CA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- The Type 2 Diabetes market is undergoing significant ...
Story May 1 - Arvinas: After Arvinas announced during its Q1 results presentation that the biotech and partner Pfizer are dropping two phase 3 trials from their estrogen receptor degrader R&D plan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results